Merck Provides U.S. Regulatory Update on Gefapixant
Go back to Merck Provides U.S. Regulatory Update on Gefapixant| Merck & Co. (NYSE: MRK) | Delayed: 120.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.76 | 52 Week High | $65.46 | |||
| Open | $120.76 | 52 Week Low | $47.97 | |||
| Day High | $120.76 | P/E | 82.15 | |||
| Day Low | $120.76 | EPS | $1.47 | |||
| Volume | 1,178 | |||||
